YAN BAI: Open Payments
NPI 1558612804 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 76 payments from 22 companies in 2025. Trend: 2023 $1,953 · 2024 $3,219 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $292 |
| Novo Nordisk Inc | 5 | $202 |
| Amgen Inc. | 8 | $189 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Almatica Pharma LLC | 5 | $124 |
| Oyster Point Pharma, Inc. | 5 | $108 |
| Kowa Pharmaceuticals America, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $100 |
| Aimmune Therapeutics, Inc. | 3 | $82 |
| Ardelyx, Inc. | 3 | $78 |
Products named: Kerendia, Ozempic, REXULTI, LOREEV XR, BREZTRI, TYRVAYA, ZORYVE, ZENPEP.
Industry payments across CA — which companies pay providers there.
